Observational Study to Assess Sociodemographic and Clinical Features of Patients Treated With Rivaroxaban in Routine Clinical Practice of Hematologists, Cardiologists and Internists of Spain "HEROIC"


Phase N/A Results N/A

Trial Description

Depict demographic and clinical features of patients with atrial fibrillation treated with rivaroxaban to prevent stroke and pulmonary embolism in routine clinical practice



  • Rivaroxaban (Xarelto, BAY59-7939) Drug
    Intervention Desc: Patients treated by Physicians under approved local prescriptions
    ARM 1: Kind: Experimental
    Label: Rivaroxaban
    Description: Patients with Atrial fibrillation treated with Rivaroxaban

Trial Design

  • Observation: Cohort
  • Perspective: Cross-Sectional
  • Sampling: Non-Probability Sample

Trial Population

Patients taking rivaroxaban for stroke prevention in atrial fibrillation attending consults of hematology, cardiology and internal medicine


Type Measure Time Frame Safety Issue
Primary Demographic Data At recruitment visit No
Primary Medical History At recruitment visit No
Secondary Assess regional differences among the different Spanish autonomous communities on the management of patients with rivaroxaban treatment during the routine clinical practice At recruitment visit No
Secondary Adherence to rivaroxaban treatment At recruitment visit No
Secondary Assess the satisfaction of rivaroxaban treatment At recruitment visit No
Secondary Assess the quality of life in patients At recruitment visit No